Total Payments
$170,465
2024 Payments
$31,904
Companies
34
Transactions
535
Medicare Patients
1,246
Medicare Billing
$187,686
Payment Breakdown by Category
Other$146,120 (85.7%)
Travel$13,744 (8.1%)
Food & Beverage$10,585 (6.2%)
Education$16.33 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $92,820 | 49 | 54.5% |
| Compensation for serving as faculty or as a speaker for a medical education program | $27,700 | 11 | 16.2% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $25,600 | 11 | 15.0% |
| Travel and Lodging | $13,744 | 53 | 8.1% |
| Food and Beverage | $10,585 | 410 | 6.2% |
| Education | $16.33 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $78,637 | 138 | $0 (2024) |
| Synergy Pharmaceuticals Inc | $30,948 | 45 | $0 (2018) |
| IRONWOOD PHARMACEUTICALS, INC | $19,248 | 47 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $16,291 | 37 | $0 (2024) |
| ABBVIE INC. | $15,407 | 124 | $0 (2024) |
| RedHill Biopharma Inc. | $5,345 | 14 | $0 (2021) |
| Valeant Pharmaceuticals North America LLC | $2,183 | 9 | $0 (2017) |
| Allergan Inc. | $640.70 | 20 | $0 (2019) |
| Gilead Sciences, Inc. | $302.27 | 22 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $249.34 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $31,904 | 85 | Phathom Pharmaceuticals, Inc. ($16,291) |
| 2023 | $22,334 | 59 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($14,508) |
| 2022 | $25,874 | 80 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($16,015) |
| 2021 | $22,552 | 91 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($16,750) |
| 2020 | $9,176 | 47 | RedHill Biopharma Inc. ($4,522) |
| 2019 | $20,617 | 56 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($20,274) |
| 2018 | $14,097 | 58 | Synergy Pharmaceuticals Inc ($9,764) |
| 2017 | $23,911 | 59 | Synergy Pharmaceuticals Inc ($21,184) |
All Payment Transactions
535 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: VIROLOGY | ||||||
| 12/04/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $6.40 | General |
| Category: VIROLOGY | ||||||
| 11/04/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/30/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $9.10 | General |
| Category: GI | ||||||
| 10/29/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: LIVER DISEASE | ||||||
| 10/23/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $6.93 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/17/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,375.00 | General |
| Category: GI | ||||||
| 10/02/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $12.67 | General |
| Category: VIROLOGY | ||||||
| 09/18/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Travel and Lodging | Cash or cash equivalent | $478.16 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/18/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | Cash or cash equivalent | $2.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/06/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $121.44 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/31/2024 | Celltrion USA Inc. | ZYMFENTRA (Biological) | Education | In-kind items and services | $16.33 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/26/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/19/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $13.32 | General |
| 08/12/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,375.00 | General |
| 08/07/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,720.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/31/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $114.58 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/31/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $14.72 | General |
| Category: GI | ||||||
| 07/27/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $55.61 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/27/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $47.87 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/27/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $35.23 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/27/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $29.30 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/27/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $29.30 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/26/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Travel and Lodging | In-kind items and services | $346.09 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/26/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Travel and Lodging | In-kind items and services | $283.47 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 235 | 324 | $115,475 | $35,231 |
| 2022 | 5 | 252 | 369 | $130,945 | $37,547 |
| 2021 | 6 | 277 | 436 | $142,715 | $50,343 |
| 2020 | 11 | 482 | 952 | $286,450 | $64,565 |
Total Patients
1,246
Total Services
2,081
Medicare Billing
$187,686
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 105 | 193 | $46,320 | $18,778 | 40.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 58 | 58 | $21,170 | $7,522 | 35.5% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 22 | 22 | $19,140 | $4,121 | 21.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 29 | 29 | $13,775 | $2,417 | 17.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 21 | 22 | $15,070 | $2,392 | 15.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 121 | 237 | $56,780 | $21,996 | 38.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 50 | 50 | $18,250 | $5,911 | 32.4% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 27 | 27 | $23,490 | $5,588 | 23.8% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 29 | 30 | $20,550 | $2,258 | 11.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 25 | 25 | $11,875 | $1,795 | 15.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 132 | 291 | $69,940 | $30,039 | 42.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 57 | 57 | $20,495 | $8,145 | 39.7% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 22 | 22 | $19,140 | $4,805 | 25.1% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 36 | 36 | $16,805 | $3,605 | 21.5% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 19 | 19 | $13,015 | $2,580 | 19.8% |
| 46600 | Diagnostic examination of the anus using an endoscope | Office | 2021 | 11 | 11 | $3,320 | $1,168 | 35.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 166 | 387 | $96,750 | $33,467 | 34.6% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2020 | 58 | 252 | $25,200 | $8,389 | 33.3% |
| 45380 | Biopsy of large bowel using an endoscope | Facility | 2020 | 48 | 48 | $72,000 | $5,498 | 7.6% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 36 | 37 | $37,000 | $3,987 | 10.8% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 27 | 27 | $9,450 | $3,563 | 37.7% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope | Facility | 2020 | 16 | 16 | $24,000 | $3,536 | 14.7% |
| 88342 | Tissue or cell analysis by immunologic technique | Office | 2020 | 28 | 62 | $6,200 | $1,985 | 32.0% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 42 | 47 | $7,050 | $1,849 | 26.2% |
| 46600 | Diagnostic examination of the anus using an endoscope | Office | 2020 | 12 | 12 | $2,400 | $1,184 | 49.3% |
About Dr. Ramesh Gupta, M.D
Dr. Ramesh Gupta, M.D is a Gastroenterology healthcare provider based in Fair Lawn, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/29/2005. The National Provider Identifier (NPI) number assigned to this provider is 1205813391.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ramesh Gupta, M.D has received a total of $170,465 in payments from pharmaceutical and medical device companies, with $31,904 received in 2024. These payments were reported across 535 transactions from 34 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($92,820).
As a Medicare-enrolled provider, Gupta has provided services to 1,246 Medicare beneficiaries, totaling 2,081 services with total Medicare billing of $187,686. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Fair Lawn, NJ
- Active Since 12/29/2005
- Last Updated 02/28/2012
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1205813391
Products in Payments
- TRULANCE (Drug) $45,874
- Trulance (Drug) $30,948
- XIFAXAN (Drug) $30,703
- Linzess (Drug) $19,212
- VOQUEZNA (Drug) $16,291
- LINZESS (Drug) $8,330
- Talicia (Drug) $5,298
- PLENVU (Drug) $4,177
- VIBERZI (Drug) $359.13
- MAVYRET (Drug) $337.96
- ZEPOSIA (Drug) $249.34
- CREON (Drug) $204.72
- XELJANZ (Drug) $162.85
- Mavyret (Drug) $118.40
- IBSRELA (Drug) $105.68
- SUCRAID (Drug) $83.66
- Creon (Drug) $75.95
- Donnatal (Drug) $71.36
- NASCOBAL (Drug) $70.89
- ZENPEP (Drug) $69.08
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Fair Lawn
Gary Gorodokin, Md, MD
Gastroenterology — Payments: $15,864
Gastroenterology $15,864
Dr. Donald Kutner, Do, DO
Gastroenterology — Payments: $6,549
Gastroenterology $6,549
Jeffrey Lefkowitz, Md, MD
Gastroenterology — Payments: $5,449
Gastroenterology $5,449
Dr. Jonathan Resnick, Md, MD
Gastroenterology — Payments: $3,830
Gastroenterology $3,830
Youssef Botros
Gastroenterology — Payments: $2,817
Gastroenterology $2,817
Kuchipudi Bapineedu, Md, MD
Gastroenterology — Payments: $674.39
Gastroenterology $674.39